 | Up a level |
Prümmer, Julia K; Stein, Veronika M; Marti, Eliane; Lutterotti, Andreas; Jelcic, Ilijas; Schüpbach-Regula, Gertraud; Buch, Thorsten; Maiolini, Arianna (2023). Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin. PLoS ONE, 18(1), e0280864. Public Library of Science 10.1371/journal.pone.0280864
Achtnichts, Lutz; Zecca, Chiara; Findling, Oliver; Kamm, Christian P; Mueller, Stefanie; Kuhle, Jens; Lutterotti, Andreas; Gobbi, Claudio; Viviani, Camille; Villiger-Borter, Emanuela; Nedeltchev, Krassen (2023). Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS). BMJ neurology open, 5(1), e000304. British Medical Association 10.1136/bmjno-2022-000304
Prümmer, Julia K; Stein, Veronika M; Marti, Eliane; Ziegler, Mario; Lutterotti, Andreas; Jelcic, Ilijas; Steffen, Frank; Buch, Thorsten; Maiolini, Arianna (2022). Comparison of Two Different Canine Anti-IgG Antibodies for Assessment of Oligoclonal Bands in Cerebrospinal Fluid and Serum of Dogs via Isoelectric Focusing Followed by an Immunoblot. Frontiers in veterinary science, 9, p. 873456. Frontiers Media 10.3389/fvets.2022.873456
Wiendl, Heinz; Gold, Ralf; Berger, Thomas; Derfuss, Tobias; Linker, Ralf; Mäurer, Mathias; Stangel, Martin; Aktas, Orhan; Baum, Karl; Berghoff, Martin; Bittner, Stefan; Chan, Andrew Hao-Kuang; Czaplinski, Adam; Deisenhammer, Florian; Di Pauli, Franziska; Du Pasquier, Renaud; Enzinger, Christian; Fertl, Elisabeth; Gass, Achim; Gehring, Klaus; ... (2021). [Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]. Der Nervenarzt, 92(8), pp. 773-801. Springer 10.1007/s00115-021-01157-2
Wiendl, Heinz; Gold, Ralf; Berger, Thomas; Derfuss, Tobias; Linker, Ralf; Mäurer, Mathias; Aktas, Orhan; Baum, Karl; Berghoff, Martin; Bittner, Stefan; Chan, Andrew; Czaplinski, Adam; Deisenhammer, Florian; Di Pauli, Franziska; Du Pasquier, Renaud; Enzinger, Christian; Fertl, Elisabeth; Gass, Achim; Gehring, Klaus; Gobbi, Claudio; ... (2021). Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic advances in neurological disorders, 14, p. 17562864211039648. Sage 10.1177/17562864211039648
Achtnichts, Lutz; Chan, Andrew; Czaplinski, Adam; Derfuss, Tobias; Du Pasquier, Renaud; Findling, Oliver; Gobbi, Claudio; Hoepner, Robert; Kamber, Nicole; Kamm, Christian P.; Kuhle, Jens; Lalive, Patrice; Lutterotti, Andreas; Martin, Roland; Mller, Stefanie; Papadopoulou, Athina; Pot, Caroline; Salmen, Anke; Schippling, Sven and Zecca, Chiara (2019). Besonderheiten der Immuntherapie der Multiplen Sklerose in der Schweiz. Swiss Medical Forum, 19(41-42), pp. 676-685. EMH Swiss Medical Publishers 10.4414/smf.2019.08356
Lassmann, Hans; Reindl, Markus; Rauschka, Helmut; Berger, Johannes; Aboul‐Enein, Fahmy; Berger, Thomas; Zurbriggen, Andreas; Lutterotti, Andreas; Brück, Wolfgang; Weber, Jörg R.; Ullrich, Robert; Schmidbauer, Manfred; Jellinger, Kurt; Vandevelde, Marc (2003). A new paraclinical CSF marker for hypoxia‐like tissue damage in multiple sclerosis lesions. Brain, 126(6), pp. 1347-1357. Oxford University Press 10.1093/brain/awg127
